… diagnosis and treatment of acute and chronic heart failure. In addition, quality of life
assessment was performed using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). …

… of sacubitril/valsartan vs. enalapril in Japanese patients with chronic heart failure with
reduced … This open-label extension (OLE) assessed long-term safety with sacubitril/valsartan. …

… (1) acute decompensated heart failure participants compared with chronic heart failure
participants (p=0.53); (2) different types of control intervention (valsartan, enalapril and benazepril…

… Importance In patients with heart failure and reduced ejection fraction (HFrEF), treatment
with sacubitril-valsartan … The effect of sacubitril-valsartan on cardiac remodeling is uncertain. …

… Sacubitril/valsartan reduces NT-proBNP in heart failure (HF) with both reduced and …
and cardiovascular death compared with valsartan in patients with HF with preserved EF (HFpEF). …

… -valsartan in male patients with heart failure with reduced ejection fraction (n = 9). For all
panels, the left and right boxplots represent baseline and after two months of treatment with …

… heart failure (HF) treated with Sacubitril/Valsartan, previously found in several trials (RCTs),
are still scant. We evaluated the renal effects of Sacubitril/Valsartan … for Sacubitril/Valsartan. …

… with heart failure and reduced ejection fraction (HFrEF) with type 2 diabetes mellitus (T2DM)
have similar reverse cardiac remodeling with sacubitril/valsartan as patients without T2DM. …

… chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic
heart failure … Developed with the special contribution of the Heart Failure Association (HFA) of …

… The treatment with sacubitril/valsartan in patients suffering from chronic heart failure with …
outcome of sacubitril/valsartan in patients with chronic heart failure with reduced ejection …